10-123034380-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001609.4(ACADSB):āc.67T>Gā(p.Leu23Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000824 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADSB | NM_001609.4 | c.67T>G | p.Leu23Val | missense_variant | 2/11 | ENST00000358776.7 | NP_001600.1 | |
ACADSB | NM_001330174.3 | c.-139T>G | 5_prime_UTR_variant | 2/10 | NP_001317103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACADSB | ENST00000358776.7 | c.67T>G | p.Leu23Val | missense_variant | 2/11 | 1 | NM_001609.4 | ENSP00000357873.3 | ||
ACADSB | ENST00000368869 | c.-139T>G | 5_prime_UTR_variant | 2/10 | 2 | ENSP00000357862.4 | ||||
ACADSB | ENST00000411816.2 | n.84T>G | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152252Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251168Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135792
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461550Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727092
GnomAD4 genome AF: 0.000466 AC: 71AN: 152370Hom.: 0 Cov.: 32 AF XY: 0.000564 AC XY: 42AN XY: 74512
ClinVar
Submissions by phenotype
Deficiency of 2-methylbutyryl-CoA dehydrogenase Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 12, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 654197). This variant has not been reported in the literature in individuals affected with ACADSB-related conditions. This variant is present in population databases (rs149562178, gnomAD 0.2%). This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 23 of the ACADSB protein (p.Leu23Val). - |
ACADSB-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at